Diego Santos‐García: Influence Statistics

Diego Santos‐García

Diego Santos‐García

Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain | CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain | Department of Neurology, ...

Diego Santos‐García: Expert Impact

Concepts for which Diego Santos‐García has direct influence: Coppadis cohort , Sleep problems , Parkinson disease , Parkinsons disease , Functional dependency , Quality life , Walking economy .

Diego Santos‐García: KOL impact

Concepts related to the work of other authors for which for which Diego Santos‐García has influence: Parkinson disease , Caregiver burden , Motor symptoms , Treadmill training , Endothelial function , Quality life , Chronic pain .

KOL Resume for Diego Santos‐García

Year
2022

Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain

2021

Complejo Hospitalario Universitario de A Coruña, A Coruña, España.

2020

CHUAC (Complejo Hospitalario Universitario de A Coruña), A Coruña, España

Department of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.

2019

Department of Internal Medicine, Neurology Section, Hospital Arquitecto Marcide, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.

CHUAC, Complejo Hospitalario Universitario de A Coruña A CoruñaSpain

2017

Section of Neurology, Hospital Arquitecto Marcide/Hospital Naval, Complexo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain

2016

Sección de Neurología, Complejo Hospitalario Universitario de Ferrol (CHUF), Hospital Arquitecto Marcide, c/Avenida La Residencia, s/n, 15405 Ferrol, Spain

2015

Complejo Hospitalario Arquitecto Marcide - Profesor Novoa Santos, 15405 El Ferrol, Espana.

2014

Department of Neurology, Hospital A. Marcide, Ferrol, Spain

2013

Section of Neurology, Complejo Hospitalario Universitario de Ferrol (CHUF), Hospital A. Marcide, 15405 Ferrol, Spain

2012

Section of Neurology, Hospital A. Marcide, C/San Pedro Leixa s/n, 15405, Ferrol, Spain

2011

Stroke Unit, Department of Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Santiago de Compostela, Section of Neurology, Hospital A. Marcide, Ferrol, Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta, IdIBGi, Girona, Spain

Sección de Neurología, Hospital Arquitecto Marcide, Ferrol, A Coruña, España.

2010

Sección de Neurología, Hospital Arquitecto Marcide, Ferrol (A Coruña), Spain

Hospital Arquitecto Marcide, Ferrol, A Coruña, España.

2009

Sección de Neurología, Complexo Hospitalario Arquitecto Marcide-Novoa Santos, Ferrol, La Coruña, Spain

Servicio de Neurología, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, España.

2007

Servicio de Neurología, Complejo Hospitalario Universitario, Santiago de Compostela, Spain.

Prominent publications by Diego Santos‐García

KOL-Index: 12072 . BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder causing motor and non-motor symptoms that can affect independence, social adjustment and the quality of life (QoL) of both patients and caregivers. Studies designed to find diagnostic and/or progression biomarkers of PD are needed. We describe here the study protocol of COPPADIS-2015 (COhort of Patients with ...
Known for Serum Biomarkers | Parkinson Disease | Genetic Studies | Patients Caregivers
KOL-Index: 9548 . OBJECTIVE: To investigate the impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease (PD). METHODS: One hundred and fifty PD patients (57.3% males; 70.9±8.6years old) were included in this cross-sectional, monocenter, evaluation study. Multiple linear regression methods were used to evaluate the direct impact of non-motor symptoms (as assessed ...
Known for Motor Symptoms | Quality Life | Illness Surveys | Parkinsons Disease
KOL-Index: 8943 . BACKGROUND: Gait impairment in Parkinson's disease (PD) patients is characterized by the inability to generate appropriate stride length. Treadmill training has been proposed as a therapeutic tool for PD patients. However, it remains unknown whether treadmill training effects are different from overground walking training. Thus, our goal was to explore the effects of two training programs, ...
Known for Walking Training | Stride Length | Gait Parameters | Balance Patients
KOL-Index: 8179 . BACKGROUND AND OBJECTIVE: To analyze the main determinants of burden and stress in caregivers of Spanish Parkinson's disease (PD) patients. METHODS: One-hundred and twenty-one non-demented patients with PD (57.9% males; 70.9 ± 8.2 years old) were included in this cross-sectional, monocenter, evaluation study. Caregivers (n = 121; 71.9% females; 60.2 ± 15 years old) were assessed using the ...
Known for Zcbi Csi | Illness Cross | Factors Caregivers | Parkinson Disease
KOL-Index: 8127 . BACKGROUND: Continuous duodenal levodopa infusion (DLI) is an effective therapy that improves quality of life (QoL) in advanced Parkinson's disease (PD). However, in which aspects improve the patients their QoL has been poorly documented. METHODS: We evaluated 39-item Parkinson's disease Quality of Life Questionnaire Summary Index score (PDQ-39SI) changes analyzing its different domains in ...
Known for Quality Life | Patients Qol | Carbidopa Infusion | Duodenal Levodopa
KOL-Index: 7718 . Background and Objective: Non-motor symptoms (NMS) progress in different ways between Parkinson's disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and (3) to identify predictors of global NMS burden progression in the PD group. Material and ...
Known for Coppadis Cohort | V0 V2 | Symptoms Burden | Year Follow
KOL-Index: 7688 . BACKGROUND AND PURPOSE: Brachial arterial flow-mediated dilation (FMD) reflects endothelium-dependent vasodilation function. FMD is diminished in patients with endothelial dysfunction (ED). Our aim was to investigate the relationship between FMD and outcome for patients with acute ischemic stroke. METHODS: We measured FMD in 120 consecutive patients (58.3% male, median age 73 years) with ...
Known for Acute Ischemic Stroke | Fmd Patients | Poor Outcome | Mediated Dilation
KOL-Index: 7003 . BACKGROUND: Continuous duodenal levodopa infusion (DLI) is an effective therapy that improves quality of life (QoL) in advanced Parkinson's disease (PD). However, the impact of DLI on caregivers' stress and burden has not been reported. METHODS: We evaluated prospectively open-label seven advanced PD patients (65.7 ± 9.6 years, 71.4% men) treated with DLI. Schwab & England Activities of ...
Known for Duodenal Levodopa | Carbidopa Infusion | Parkinson Disease | Advanced Patients
KOL-Index: 6757 . BACKGROUND AND PURPOSE: In Parkinson's disease (PD), the course of the disorder is highly variable between patients. Well-designed, prospective studies for identifying PD progression biomarkers are necessary. Our aim was to show the results of baseline evaluations of an ongoing global PD project, COPPADIS-2015 (Cohort of Patients with PArkinson's DIsease in Spain, 2015). METHODS: This was ...
Known for Impulse Control | Parkinsons Disease | Baseline Evaluation | Cohort Patients
KOL-Index: 6596 . OBJECTIVE: We investigated the role of the frontostriatal system in contextual processing, by examining neural correlates of local contextual processing in Parkinson's disease (PD). Local context was defined as the occurrence of a short predictive series of visual stimuli occurring before delivery of a target event. METHODS: EEG was recorded in eight PD patients and eight controls. ...
Known for Contextual Processing | Parkinson Disease | Random Targets | Local Context
KOL-Index: 6128 . Functional connectivity was evaluated in patients with schizophrenia (SC) and in patients with Parkinson's disease (PD) during the performance of a local contextual processing paradigm, to investigate the proposition that functional disconnection is involved with contextual processing deficits in these populations. To this end, we utilized event-related EEG signals, synchronization ...
Known for Contextual Processing | Functional Connectivity | Predictive Sequence | Schizophrenia Patients
KOL-Index: 5997 . Objective: 5- (5 times oral levodopa tablet taken/day) 2- (2 hours of OFF time/day) 1- (1 hour/day of troublesome dyskinesia) criteria have been proposed by a Delphi expert consensus panel for diagnosing advanced Parkinson's disease (PD). The aim of the present study is to compare quality of life (QoL) in PD patients with "5-2-1 positive criteria" vs QoL in PD patients without "5-2-1 ...
Known for 1 Criteria | Qol Patients | 5 2 | Screening Tool
KOL-Index: 5945 . INTRODUCTION: The aim of the present study was to examine the frequency of self-reported sleep problems and their associated factors in a large cohort of PD patients. METHODS: PD patients and controls, recruited from 35 centers of Spain from the COPPADIS cohort were included in this cross-sectional study. Sleep problems were assessed by the Spanish version of the Parkinson's disease Sleep ...
Known for Sleep Problems | Symptoms Burden | Coppadis Cohort | 35 Centers
KOL-Index: 5594 . BACKGROUND AND PURPOSE: The objective of this study was to analyze the relationship between motor complications and non-motor symptom (NMS) burden in a population of patients with Parkinson's disease (PD) and also in a subgroup of patients with early PD. METHODS: Patients with PD from the COPPADIS cohort were included in this cross-sectional study. NMS burden was defined according to the ...
Known for Motor Complications | Patients Parkinson Disease | Nms Burden | Total Score

Key People For Coppadis Cohort

Top KOLs in the world
#1
Paolo Barone
parkinson disease impulse control essential tremor
#2
Pablo Martinez‐Martin
parkinson disease motor symptoms quality life
#3
Jaime J Kulisevsky
parkinson disease cognitive impairment minor hallucinations
#4
Maria José Martı́
parkinson disease cervical dystonia cortical thinning
#5
Jon Infante
spinocerebellar ataxia type parkinson disease g2019s mutation
#6
Pablo Mir
parkinson disease tourette syndrome coppadis cohort

Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain | CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain | Department of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitar